Kadimastem Ltd

Tel Aviv Stock Exchange:KDST.TA

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

💊 Pharmaceuticals

Location

Israel

Market Cap

USD 30.89 M

Share Price

USD 7.34

Avg Daily Volume

15,933

Change (1 day)

-2.48%

Change (1 year)

474.23%

Change (YTD)

105.12%

Kadimastem Ltd Total Assets for the year ending December 31, 2024

Kadimastem Ltd Total Assets is NA for the year ending December 31, 2024. Total assets are the total value of all assets owned by a company, representing its resources.

Quarterly
Annual
TTM

From:

To:

Zoom:

1Y
3Y
5Y
10Y
15Y
20Y
Max

Key data

Date	Total Assets	Accounts Payable	Short-Term Debt	Long-Term Debt

Tel Aviv Stock Exchange: KDST.TA

Kadimastem Ltd

CEO	Mr. Ronen Twito CPA
IPO Date	June 13, 2013
Location	Israel
Headquarters	Pinchas Sapir 7
Employees	11
Sector	🏥 Health Care
Industries Clinical Trials 🧬 Biotechnology 💊 Pharmaceuticals

Description

Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. Its products in pipeline include AstroRx, a clinical grade human astrocytes that is in Phase 1/2a clinical trial for the treatment of amyotrophic lateral sclerosis and other neurodegenerative diseases; and IsletRx, a clinical grade pancreatic islet cell therapy treatment for diabetes. The company was incorporated in 2008 and is based in Ness Ziona, Israel.

Similar companies

AbbVie Inc.

USD 182.31

-2.40%

Novo Nordisk A/S

USD 68.56

1.71%

Roche Holding AG

USD 347.50

0.20%

Abbott Laboratories

USD 134.38

0.53%

Novartis AG

USD 120.31

0.29%

AstraZeneca PLC

USD 140.24

0.73%

Merck & Co., Inc.

USD 79.10

0.34%

Amgen Inc.

USD 277.13

-0.71%

Pfizer Inc.

USD 24.19

-0.21%

Gilead Sciences, Inc.

USD 110.67

2.83%

Sanofi

USD 96.65

0.37%

Vertex Pharmaceuticals Incorporated

USD 441.30

-0.47%

Bristol-Myers Squibb Company

USD 46.35

-0.64%

Chugai Pharmaceutical Co., Ltd.

USD 51.91

-1.13%

GSK plc

USD 19.28

0.69%

CSL Limited

USD 153.01

-2.58%

MERCK Kommanditgesellschaft auf Aktien

USD 131.98

1.04%

Regeneron Pharmaceuticals, Inc.

USD 521.00

0.00%

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.24

-0.32%

Takeda Pharmaceutical Company Limited

USD 30.16

-0.03%

Alnylam Pharmaceuticals, Inc.

USD 322.83

1.44%

UCB SA

USD 199.41

0.97%

GE HealthCare Technologies Inc.

USD 74.38

-0.64%

Bayer AG

USD 31.61

2.81%

Celltrion, Inc.

USD 116.73

-0.46%

WuXi AppTec Co., Ltd.

USD 9.68

-1.75%

Hansoh Pharmaceutical Group Company Limited

USD 3.71

-0.01%

Laboratory Corporation of America Holdings

USD 260.59

1.41%

Insmed Incorporated

USD 99.49

-2.21%

Royalty Pharma plc

USD 35.87

1.70%

Biogen Inc.

USD 126.08

-0.66%

Astellas Pharma Inc.

USD 9.69

0.99%

Innovent Biologics, Inc.

USD 9.85

-1.60%

Summit Therapeutics Inc.

USD 20.60

-3.38%

Shionogi & Co., Ltd.

USD 17.51

-0.68%

Torrent Pharmaceuticals Limited

USD 39.09

3.96%

Genmab A/S

USD 205.20

-0.79%

Neurocrine Biosciences, Inc.

USD 125.42

-1.02%

Exelixis, Inc.

USD 43.67

1.35%

Mankind Pharma Limited

USD 27.30

1.56%

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

USD 8.56

0.65%

Regencell Bioscience Holdings Limited

USD 17.40

-13.82%

Akeso, Inc.

USD 11.78

-2.48%

Ascendis Pharma A/S

USD 172.22

-0.42%

Lupin Limited

USD 22.64

0.60%

BioMarin Pharmaceutical Inc.

USD 55.17

1.98%

Swedish Orphan Biovitrum AB (publ)

USD 29.88

2.57%

Ipsen S.A.

USD 120.09

-0.15%

Huadong Medicine Co., Ltd

USD 5.63

0.53%

StockViz Staff

June 29, 2025

Any question? Send us an email